Evoke Pharma Inc
EVOK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.13M
Close$
$1.28
88.3% downside
Current Fair Value
88.3% downsideOvervalued by 88.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $28.13 Million |
|---|---|
| Enterprise Value | $16.67 Million |
| Earnings per Share | $-2.81 |
| Beta | -0.14 |
| Outstanding Shares | 2,557,408 |
Return
| Return on Equity | -155.44% |
|---|---|
| Return on Assets | -33.39% |
| Return on Invested Capital | -141.81% |
Valuation & Multiples
| P/E Ratio | -10.28 |
|---|---|
| PEG | 86.39 |
| Price to Sales | 2.2 |
| Price to Book Ratio | 11.0 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -3.45 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 13, 2025
EPS Estimate
$-0.45
Consensus analyst estimateRevenue Estimate
$4.33 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Evoke Pharma Inc
CEO: David Gonyer
